- 12 August
-
Experts from the Russian Ministry of Health have included the TRIAZAVIRIN® antiviral drug in the guidelines «Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection COVID-19» (version No. 19 dated 27/5/2025).
- 17 June
-
From May 20 to 22, the first Eurasian International Medical Forum was held in Ekaterinburg. The event was dedicated to the 80th anniversary of Victory in the Great Patriotic War. The Forum brought together over 1,000 participants and 250 experts from Russia, India, China and Belarus. Medsintez Plant took an active part in scientific program of the Forum and demonstrated its latest developments in the field of import-substituting drugs.
- 13 June
-
The X (XXXI) National Diabetes Congress with international participation was held in Moscow from May 27 to 30, 2025. The event was dedicated to the topic «Diabetes mellitus – a non-infectious pandemic of the 21st century. Macro- and microvascular complications. Issues of interdisciplinary interaction». The Congress was dedicated to the 100th anniversary of the Russian Association of Endocrinologists, the Endocrinology Service of the Russian Federation and the Research Center for Endocrinology.
- 10 June
-
In May 2025, pharmaceutical plant Medsintez Plant LLC joined the leading enterprises that were awarded the status of National Champion based on the results of a comprehensive expert selection. Getting the status of National Champion is a significant event for Medsintez Plant, which emphasizes its contribution to the development of the pharmaceutical industry and strengthening the drug safety of Russia.
- Home
- Cluster members
- Paradigma LLC
Paradigma LLC
Paradigma LLC is a dynamically developing company specializing in the production and treatment of medical devices. The company successfully operates in the market of medical products and offers comprehensive solutions for health care facilities.
Main areas of activity
- Production of KAP (a liquid embolic system) – manufacturing of specialized medical systems
- Production of syringe kits – manufacturing of components for medical equipment
- Sterilization services – professional treatment of medical devices
Paradigma LLC has launched a sterilization center of (low-temperature) gas sterilization, which allows us to manufacture sterile medical products for the end user. The production capacity of the company allows it to sterilize not only its own products, but also to provide sterilization services to third-party customers.
For the convenience of our customers, we offer services for packaging products in corrugated boxes. The customer can place an order for sterilization of one corrugated box, one cubic meter, or fill the entire useful capacity of the gas chamber with their products. The price of the sterilization service is set individually depending on the volume of products, duration and mode of the cycle.
We have equipped our own high-tech production facilities for the manufacture of syringe kits suitable for a wide range of devices for the intravenous administration of radiopaque substances, which allows us to control the product quality at all stages.
- Quality control at all stages of production. Use of modern technologies and equipment. Wide range of products.
- Flexibility in production of individual orders.
- Our syringe kits meet all quality requirements and standards, which is confirmed by the relevant certificates.
- We offer our customers favorable terms of cooperation, individual approach and fast delivery of products.
Own production of KAP
Sterile, non-absorbable, non-adhesive, X-ray contrast polymer implant for embolization of vascular lesions in various clinical situations. It can be used, among other things, for embolization in case of cerebral vascular pathology, including arteriovenous malformations and hypervascular tumors.
KAP is a liquid embolic system made of the following components:
Ethylene-vinyl alcohol copolymer (EVOH)
Dimethyl sulfoxide (DMSO)
Micronized tantalum powder (Ta)
KAP is able to penetrate into the bloodstream to a given depth (depending on the selected viscosity), thereby ensuring total occlusion of target vessels.
40/4 Gurzufskaya St., 620102 Ekaterinburg
Tel.: (343) 286-14-57
E-mail: paradigma2000@mail.ru
www.angio.pro
